On the other hand, the low neurotoxicity, promising neuroprotection, and relatively good inhibitory MAO-B effects of the underlined derivative 12 may be a good starting point in the future development of perspective agents affecting Parkinson’s conditions. This evidence concerns the gene MAOB and Parkinson disease.